EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation

Katharina Och, Amin T Turki, Katharina M Götz, Dominik Selzer, Christian Brossette, Stefan Theobald, Yvonne Braun, Norbert Graf, Jochen Rauch, Kerstin Rohm, Gabriele Weiler, Stephan Kiefer und 13 weitere

Cancer Medicine · 2024

DOI: 10.1002/cam4.6833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Katharina Och und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Transplantation, Homologous, Transplantation Conditioning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute graft‐versus‐host disease (aGvHD) is a major cause of death for patients following allogeneic hematopoietic stem cell transplantation (HSCT). Effective management of moderate to severe aGvHD remains challenging despite recent advances in HSCT, emphasizing the importance of prophylaxis and risk factor identification.

Methods

In this study, we analyzed data from 1479 adults who underwent HSCT between 2005 and 2017 to investigate the effects of aGvHD prophylaxis and time‐dependent risk factors on the development of grades II–IV aGvHD within 100 days post‐HSCT.

Results

Using a dynamic longitudinal time‐to‐event model, we observed a non‐monotonic baseline hazard overtime with a low hazard during the first few days and a maximum hazard at day 17, described by Bateman function with a mean transit time of approximately 11 days. Multivariable analysis revealed significant time‐dependent effects of white blood cell counts and cyclosporine A exposure as well as static effects of female donors for male recipients, patients with matched related donors, conditioning regimen consisting of fludarabine plus total body irradiation, and patient age in recipients of grafts from related donors on the risk to develop grades II–IV aGvHD. Additionally, we found that higher cumulative hazard on day 7 after allo‐HSCT are associated with an increased incidence of grades II–IV aGvHD within 100 days indicating that an individual assessment of the cumulative hazard on day 7 could potentially serve as valuable predictor for later grades II–IV aGvHD development. Using the final model, stochastic simulations were performed to explore covariate effects on the cumulative incidence over time and to estimate risk ratios.

Conclusion

Overall, the presented model showed good descriptive and predictive performance and provides valuable insights into the interplay of multiple static and time‐dependent risk factors for the prediction of aGvHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningHumansMaleFemaleAdultMiddle AgedRisk FactorsYoung AdultAcute DiseaseTime FactorsAdolescentAgedCyclosporine

Stichwörter der Autor:innen

acute graft‐versus‐host diseaseallogeneic hematopoietic stem cell transplantationcyclosporine arisk factorstime‐to‐event model

Substanzen

Cyclosporine

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Saarland University, Saarbrücken, Germany.
  • Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, Essen, Germany.
  • Department of Pediatric Oncology and Hematology, Saarland University, Homburg, Germany.
  • Department of Biomedical Data & Bioethics, Fraunhofer Institute for Biomedical Engineering (IBMT), Sulzbach, Germany.
  • Institute for Formal Ontology and Medical Information Science, Saarland University, Saarbrücken, Germany.
  • Department of Computer Science, University of Tübingen, Tübingen, Germany.

ORCID-Profile: Thorsten Lehr

Zitieren

APA

Och, K., Turki, A. T., Götz, K. M., Selzer, D., Brossette, C., Theobald, S., Braun, Y., Graf, N., Rauch, J., Rohm, K., Weiler, G., Kiefer, S., Schwarz, U., Eisenberg, L., Pfeifer, N., Ihle, M., Grandjean, A., Fix, S., Riede, C., …, & Lehr, T. (2024). A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation. Cancer Medicine. https://doi.org/10.1002/cam4.6833

Vancouver

Och K, Turki AT, Götz KM, Selzer D, Brossette C, Theobald S, et al. A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation. Cancer Medicine. 2024. doi:10.1002/cam4.6833

BibTeX
@article{Och2024,
  author = {Och, Katharina and Turki, Amin T and Götz, Katharina M and Selzer, Dominik and Brossette, Christian and Theobald, Stefan and Braun, Yvonne and Graf, Norbert and Rauch, Jochen and Rohm, Kerstin and Weiler, Gabriele and Kiefer, Stephan and Schwarz, Ulf and Eisenberg, Lisa and Pfeifer, Nico and Ihle, Matthias and Grandjean, Andrea and Fix, Sonja and Riede, Claudia and Rissland, Jürgen and Smola, Sigrun and Beelen, Dietrich W and Kaddu-Mulindwa, Dominic and Bittenbring, Jörg and Lehr, Thorsten},
  title = {A dynamic time‐to‐event model for prediction of acute graft‐versus‐host disease in patients after allogeneic hematopoietic stem cell transplantation},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.6833}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche